Brief: Arvinas And Pfizer Enter Into A Transaction With Rigel Pharmaceuticals For The Exclusive Global Rights Of Veppanu

Arvinas

12/05/2026 12:01

May 12 (Reuters) - Arvinas Inc ARVN.O:

ARVINAS AND PFIZER ENTER INTO A TRANSACTION WITH RIGEL PHARMACEUTICALS FOR THE EXCLUSIVE GLOBAL RIGHTS OF VEPPANU (VEPDEGESTRANT)

ARVINAS AND PFIZER ENTER INTO A TRANSACTION WITH RIGEL PHARMACEUTICALS FOR THE EXCLUSIVE GLOBAL RIGHTS OF VEPPANU (VEPDEGESTRANT)

ARVINAS INC - AND PFIZER TO RECEIVE $85 MILLION IN UPFRONT AND TRANSITION PAYMENTS

ARVINAS INC - AND PFIZER ELIGIBLE FOR UP TO $320 MILLION IN MILESTONE PAYMENTS AND TIERED ROYALTIES

ARVINAS INC - RIGEL TO CONTRIBUTE UP TO $40 MILLION TOWARDS ONGOING DEVELOPMENT ACTIVITIES

Source text: ID:nGNXQfxCj

Further company coverage: ARVN.O

 ((Reuters.Briefs@thomsonreuters.com;))